News Room
Miguel Garcia unveils plans for the Bio-Hub Agenda at the First Annual Meeting
Miguel Garcia, the CEO of Technophage S.A. and LxBio - Pharmaceuticals S.A., recently presented the Bio-Hub Project during the First Annual Meeting...
Annual Teambuilding event celebrated in the picturesque town of Dornes
This week marked an important occasion as Technophage and VectorB2B - Drug Development joined forces for our annual Teambuilding event. Our...
TP-102 clinical trial presented at ECCMID 2023
Last month Technophage team attended 33rd European Congress of Clinical Microbiology & Infectious Diseases with the clinical team from Israel,...
Pipeline
Invest in our products
GMP manufacturing
Learn more about GMP manufacturing
Technophage
Who we are, What we do
Therapeutic
areas
TechnoPhage is committed to the development of biological and chemical products for infection, neurosciences and ophthalmology